Referenser till artikeln "Klinisk depression och dess koppling till inflammation" av Nina Bailey, BSc, MSc, PhD Anutr

1. Simopoulos AP, "The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases", Exp Biol Med (Maywood) 2008, 233(6):674-688.
2. Hibbeln JR, "Fish consumption and major depression", Lancet 1998, 351(9110):1213.
3. Sun Q, Ma J, "Campos H, Hankinson SE, Hu FB: Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women", Am J Clin Nutr 2007, 86(1):74-81.
4. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H, "Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids", J Affect Disord 1996, 38(1):35-46.
5. Adams PB, Lawson S, Sanigorski A, Sinclair AJ, "Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression", Lipids 1996, 31 Suppl:S157-161.
6. Maes M, "Major depression and activation of the inflammatory response system", Adv Exp Med Biol 1999, 461:25-46.
7. McNamara RK, Jandacek R, Rider T, Tso P, Cole-Strauss A, Lipton JW, "Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover", Prostaglandins Leukot Essent Fatty Acids 2010, 83(4-6):185-191.
8. Jazayeri S, Tehrani-Doost M, Keshavarz SA, Hosseini M, Djazayery A, Amini H, Jalali M, Peet M, "Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder", Aust N Z J Psychiatry 2008, 42(3):192-198.
9. Jazayeri S, Keshavarz SA, Tehrani-Doost M, Djalali M, Hosseini M, Amini H, Chamari M, Djazayery A, "Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder", Psychiatry Res 2010, 178(1):112-115.
10. Martins JG, "EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials", J Am Coll Nutr 2009, 28(5):525-542.
11. Sublette ME, Ellis SP, Geant AL, Mann JJ, "Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression", J Clin Psychiatry 2011, 72(12):1577-1584.
12. Sierra S, Lara-Villoslada F, Comalada M, Olivares M, Xaus J, "Dietary eicosapentaenoic acid and docosahexaenoic acid equally incorporate as decosahexaenoic acid but differ in inflammatory effects", Nutrition 2008, 24(3):245-254.
13. Bosma-den Boer MM, van Wetten ML, Pruimboom L, "Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering", Nutr Metab (Lond) 2012, 9(1):32.
14. Jokinen J, Nordstrom P, "HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients", J Affect Disord 2009, 116(1-2):88-92.
15. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL, "A meta-analysis of cytokines in major depression", Biol Psychiatry 2010, 67(5):446-457.
16. Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, Schneider HG, Leonard BE, Berk M, "Association of high-sensitivity C-reactive protein with de novo major depression", Br J Psychiatry 2010, 197(5):372-377.
17. Berk M, Williams LJ, Jacka FN, O'Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML et al, "So depression is an inflammatory disease, but where does the inflammation come from?", BMC Med 2013, 11:200.
18. Janelidze S, Mattei D, Westrin A, Traskman-Bendz L, Brundin L, "Cytokine levels in the blood may distinguish suicide attempters from depressed patients", Brain Behav Immun 2011, 25(2):335-339.
19. Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A et al, "Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease", Brain 1992, 115 ( Pt 5):1249-1273.
20. Oxenkrug GF, "Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later", Isr J Psychiatry Relat Sci 2010, 47(1):56-63.
21. Howren MB, Lamkin DM, Suls J, "Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis", Psychosom Med 2009, 71(2):171-186.
22. Swardfager W, Herrmann N, Dowlati Y, Oh PI, Kiss A, Walker SE, Lanctot KL, "Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease", Psychoneuroendocrinology 2009, 34(10):1560-1566.
23. Huang H, Fan X, Williamson DE, Rao U, "White matter changes in healthy adolescents at familial risk for unipolar depression: a diffusion tensor imaging study", Neuropsychopharmacology 2011, 36(3):684-691.
24. Salvadore G, Nugent AC, Lemaitre H, Luckenbaugh DA, Tinsley R, Cannon DM, Neumeister A, Zarate CA, Jr., Drevets WC, "Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder", Neuroimage 2011, 54(4):2643-2651.
25. Kempton MJ, Salvador Z, Munafo MR, Geddes JR, Simmons A, Frangou S, Williams SC, "Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder", Arch Gen Psychiatry 2011, 68(7):675-690.
26. Song C, Li X, Kang Z, Kadotomi Y, "Omega-3 fatty acid ethyl-eicosapentaenoate attenuates IL-1beta-induced changes in dopamine and metabolites in the shell of the nucleus accumbens: involved with PLA2 activity and corticosterone secretion", Neuropsychopharmacology 2007, 32(3):736-744.
27. Malynn S, Campos-Torres A, Moynagh P, Haase J, "The pro-inflammatory cytokine TNF-alpha regulates the activity and expression of the serotonin transporter (SERT) in astrocytes", Neurochem Res 2013, 38(4):694-704.
28. Su KP, Lai HC, Yang HT, Su WP, Peng CY, Chang JP, Chang HC, Pariante CM, "Omega-3 Fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial", Biol Psychiatry 2014, 76(7):559-566.